[Federal Register Volume 62, Number 57 (Tuesday, March 25, 1997)]
[Notices]
[Page 14159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-7375]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Allergy and Infectious Diseases; Closed
Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute of Allergy and Infectious Diseases Special Emphasis
Panel (SEP) meetings.
Name of SEP: Mechanisms of AIDS Pathogenesis and Novel HIV
Vaccine Design (Telephone Conference Call).
Date: April 2, 1997.
Time: 12 p.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 1A4, Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Paula Strickland, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., 1A4, Bethesda, MD 20892,
(301) 496-2550.
Purpose/Agenda: To evaluate contract proposals.
Name of SEP: Cost Effectiveness of Preventing HIV Complications
(Telephone Conference Call).
DATE: April 3, 1997.
TIME: 2 p.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 4C01, Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Dianne E. Tingley, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C07, Bethesda, MD
20892, (301) 496-2550.
Purpose/Agenda: To evaluate grant application.
Name of SEP: Innovative Drug Discovery Research in AIDS
Opportunistic Infections (Telephone Conference Call).
Date: April 10, 1997.
Time: 12 p.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 1A4, Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Paula Strickland, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C02, Bethesda, MD
20892, (301) 402-0643
Purpose/Agenda: To evaluate grant applications.
These meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
This notice is being published less than 15 days prior to the
above meetings due to the urgent need to meet timing limitations
imposed by the review and funding cycle.
(Catalog of Federal Domestic Assistance Programs Nos. 93.855,
Immunology, Allergic and Immunologic Diseases Research; 93.856,
Microbiology and Infections Diseases Research, National Institutes
of Health)
Dated: March 19, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 97-7375 Filed 3-24-97; 8:45 am]
BILLING CODE 4140-01-M
